Their proposal, “A Data-Driven Approach to Urban Mobility,” leverages advancements in artificial intelligence, data analytics and Internet of Things (IoT) technologies to revitalize the Metropolitan Transit Authority (MTA).
Dr. Rinu Abraham, a recent graduate of the Katz School’s Occupational Therapy Doctorate, was the corresponding author of a study that found a negative correlation between manual dexterity and cognitive function in individuals with Multiple Sclerosis.
From June 2nd to June 6th, 2024, the Straus Center participated in a summer seminar in England. The program featured leading diplomats, writers, academics, and Chief Rabbi Ephraim Mirvis.
The projects, drawn across the school’s graduate programs in STEM and Health Sciences, covered a range of subjects, and was an outcome of their own scholarship, as well as mentorship from app advisors, research collaborators and industry representatives.
A first-generation American in a family of health care providers, Sharona Abramova was drawn to the PA app’s reputation for clinical excellence and the curriculum that emphasizes compassionate care. She recently joined Maimonides Midwood Community Hospital as a PA.
This summer, the Straus Center Impact Office will be supporting several Straus Scholars and other top YU students as they pursue exciting professional advancement opportunities in the fields of politics, policy, journalism, academia, and Jewish advocacy.
Adina Feldman (SCW '26) is a Straus Scholar majoring in Psychology. Over the course of the 2023-2024 school year, Feldman was active on and off campus, pursuing a variety of unique extracurriculars and professional enrichment opportunities.
Daniel Ganopolsky (YC ’24) is a Straus Scholar majoring in political science. In the spring of 2024, he interned at the New app City Family Court, and was supported by a grant from the Straus Center’s Impact Office.
Collaborations, like the one between Weill Cornell Medicine and the Katz School’s M.S. in Biotechnology Management and Entrepreneurship, have emerged as catalysts for the development of the next generation of drugs, devices and services.